NTRA Quote, Financials, Valuation and Earnings

Delcath Systems has a net margin of -11.3% compared to Natera's net margin of -22.5%. Natera's return on equity of -21.3% beat Delcath Systems's return on equity of -117.89%.

Natera has a consensus price target of $195.26, signalling upside risk potential of 20.11%. On the other hand Delcath Systems has an analysts' consensus of $23.00 which suggests that it could grow by 60.22%. Given that Delcath Systems has higher upside potential than Natera, analysts believe Delcath Systems is more attractive than Natera.

Natera has a beta of 1.794, which suggesting that the stock is 79.445% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.722, suggesting its less volatile than the S&P 500 by 27.805%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

Natera quarterly revenues are $476.1M, which are larger than Delcath Systems quarterly revenues of $15.1M. Natera's net income of -$53.8M is lower than Delcath Systems's net income of -$3.4M. Notably, Natera's price-to-earnings ratio is -- while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 11.95x versus 11.35x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

Exact Sciences has a net margin of -11.3% compared to Natera's net margin of -14.32%. Natera's return on equity of -21.3% beat Exact Sciences's return on equity of -35.57%.

Natera has a consensus price target of $195.26, signalling upside risk potential of 20.11%. On the other hand Exact Sciences has an analysts' consensus of $68.81 which suggests that it could grow by 29.69%. Given that Exact Sciences has higher upside potential than Natera, analysts believe Exact Sciences is more attractive than Natera.

Natera has a beta of 1.794, which suggesting that the stock is 79.445% more volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

Natera quarterly revenues are $476.1M, which are smaller than Exact Sciences quarterly revenues of $706.8M. Natera's net income of -$53.8M is higher than Exact Sciences's net income of -$101.2M. Notably, Natera's price-to-earnings ratio is -- while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 11.95x versus 3.48x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Guardant Health has a net margin of -11.3% compared to Natera's net margin of -46.77%. Natera's return on equity of -21.3% beat Guardant Health's return on equity of -8518.58%.

Natera has a consensus price target of $195.26, signalling upside risk potential of 20.11%. On the other hand Guardant Health has an analysts' consensus of $59.33 which suggests that it could grow by 42.34%. Given that Guardant Health has higher upside potential than Natera, analysts believe Guardant Health is more attractive than Natera.

Natera has a beta of 1.794, which suggesting that the stock is 79.445% more volatile than S&P 500. In comparison Guardant Health has a beta of 1.489, suggesting its more volatile than the S&P 500 by 48.904%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Guardant Health pays out -- of its earnings as a dividend.

Natera quarterly revenues are $476.1M, which are larger than Guardant Health quarterly revenues of $203.5M. Natera's net income of -$53.8M is higher than Guardant Health's net income of -$95.2M. Notably, Natera's price-to-earnings ratio is -- while Guardant Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 11.95x versus 6.64x for Guardant Health. Usually stocks with elevated PS ratios are considered overvalued.

Star Equity Holdings has a net margin of -11.3% compared to Natera's net margin of -14.37%. Natera's return on equity of -21.3% beat Star Equity Holdings's return on equity of -17.45%.

Natera has a consensus price target of $195.26, signalling upside risk potential of 20.11%. On the other hand Star Equity Holdings has an analysts' consensus of $10.00 which suggests that it could grow by 325.64%. Given that Star Equity Holdings has higher upside potential than Natera, analysts believe Star Equity Holdings is more attractive than Natera.

Natera has a beta of 1.794, which suggesting that the stock is 79.445% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.871, suggesting its less volatile than the S&P 500 by 12.92%.

Natera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

Natera quarterly revenues are $476.1M, which are larger than Star Equity Holdings quarterly revenues of $17.1M. Natera's net income of -$53.8M is lower than Star Equity Holdings's net income of -$2.5M. Notably, Natera's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera is 11.95x versus 0.14x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.